Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 110.1 | 97.4 | 82.3 | 87.9 | 88.0 | 82.3 | 91.8 | 145.3 |
| Revenue growth | 13.0% | 18.3% | -6.3% | -0.1% | 6.9% | -10.4% | -36.8% | -59.0% |
| Cost of goods sold | 95.3 | 82.9 | 70.3 | 78.0 | 80.4 | 79.0 | 91.0 | 291.3 |
| Gross profit | 14.9 | 14.5 | 12.1 | 9.9 | 7.6 | 3.3 | 0.7 | -146.0 |
| Gross margin | 13.5% | 14.9% | 14.6% | 11.2% | 8.6% | 4.0% | 0.8% | -100.5% |
| Selling, general and administrative | 14.5 | 12.6 | 12.0 | 13.7 | 10.5 | 13.1 | 22.0 | 27.8 |
| Research and development | | | | | | 0.0 | 0.3 | 0.8 |
| EBIT | 0.4 | 1.9 | 0.1 | -4.3 | -2.0 | -12.1 | -22.8 | -28.3 |
| EBIT margin | 0.3% | 2.0% | 0.1% | -4.9% | -2.3% | -14.8% | -24.8% | -19.5% |
| Pre-tax income | -1.5 | 4.0 | -1.3 | -4.0 | -3.7 | -11.4 | 6.3 | -25.2 |
| Income taxes | 0.9 | 1.1 | -3.0 | 0.0 | -0.2 | -0.6 | 0.3 | 2.0 |
| Tax rate | | 26.9% | 229.1% | 0.1% | 5.5% | 5.4% | 4.7% | |
| Net income | -2.5 | 2.9 | 1.7 | -3.9 | -3.5 | -10.8 | 6.0 | -27.2 |
| Net margin | -2.3% | 3.0% | 2.0% | -4.5% | -4.0% | -13.2% | 6.6% | -18.7% |
| |
| Diluted EPS | ($0.11) | $0.13 | $0.08 | ($0.19) | ($0.17) | ($0.53) | $0.30 | ($1.38) |
| Shares outstanding (diluted) | 21.7 | 23.0 | 21.1 | 20.9 | 20.5 | 20.3 | 19.9 | 19.7 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|